Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Boy drowns in Rio Grande
Steps down as Fox chairman
Murdaugh pleads guilty
'I can't do it anymore'
‘Sick of being with myself’
‘I was killing myself’
To pay $20K/month to ex-wife
3 navy crew members killed
Vows expanded travel ban
Teen stuck dangling, rescued
5 RU spies charged in UK?
Visits Notre-Dame
Migrants offered legal status
Romania gas explosion kills 4
Record traffic to Vote.Org
Cold War spy program
$340K for years in prison
Advocates for gun safety
Outlines new GOP plan
'Invasion at TX-MX border'
IN suspends Canadian visas
Security upgrades to prison
'Dance First' trailer
Zelenskyy to meet Biden
Glynn Simmons exonerated
Ken Paxton attacks rivals
Facebook unveils new logo
Broadcom stock tumbles
Kirksey to retire from NFL
Garland defends DOJ
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
209,000 results
ScienceAlert on MSN
14h
This FDA-Approved Drug Slows Down Alzheimer's. We Finally Know Why.
Lecanemab received FDA approval in January after a phase 3 trial showed it slows cognitive decline in early-stage Alzheimer's ...
朝日新聞社6d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...
朝日新聞社25d
FDA approves much-debated Alzheimer’s drug panned by experts
FDA approves much-debated Alzheimer’s drug panned by experts THE ASSOCIATED PRESS June 8, 2021 at 09:15 JST Share Tweet list Print In this 2019 photo provided by Biogen, a researcher works on ...
Yahoo Finance1mon
Tiziana Life Sciences gets FDA green light to investigate potential Alzheimer's treatment
Tiziana Life Sciences Ltd (NASDAQ:TLSA) chief medical officer and chief operating officer Matthew Davis speaks to Thomas Warner from Proactive after announcing that Tiziana has received FDA ...
Medical Xpress19d
Unlocking how the new Alzheimer's drug lecanemab works
Approved by the FDA earlier this year, the Alzheimer's therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide called amyloid-beta (Aβ), which is thought to be ...
Afro9d
Why is Medicare rationing Alzheimer’s drugs?
The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
New York Post28d
The FDA is now fast-tracking new drug approvals — why that’s so worrying
The Food and Drug Administration is now regularly approving new drugs after just one or two clinical trials — a significant departure from the more rigorous vetting process the agency was ...
6h
Alzheimer's Association Of LI Shares Importance Of Early Detection
The FDA approved two treatments to slow Alzheimer's. World Alzheimer's Day is Thursday, a global effort to raise awareness of ...
1d
MIT’s A11 Drug: Reducing Inflammation and Enhancing Memory in Alzheimer’s Disease
A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons, and improving cognition in preclinical tests.
The Financial Times18d
Vivek Ramaswamy’s FDA ‘corruption’ claims disavowed by Roivant
We’ll send you a myFT Daily Digest email rounding up the latest Vivek Ramaswamy news every morning. US biotech company Roivant Sciences has moved to distance itself from its founder, Vivek ...
Salon7d
Navigating new Alzheimer's drugs can be confusing and expensive. So do they really help patients?
For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...
2h
Diabetes drug maker sues over compounded versions of Mounjaro
Another diabetes drug maker is taking legal action against businesses in several states, alleging that they're "fraudulently ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices